2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koulmanda, M; Mackay, IR; Mandel, TE | 1 |
1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Prevention of spontaneous and cyclophosphamide-induced diabetes in non-obese diabetic (NOD) mice with oral 2-acetyl-4-tetrahydroxybutylimidazole (THI), a component of caramel colouring III.
Topics: Administration, Oral; Animals; CD4 Antigens; CD8 Antigens; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Flow Cytometry; Imidazoles; Lymphopenia; Mice; Mice, Inbred NOD; Spleen; T-Lymphocytes; Thymus Gland | 1992 |